Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Griffiths

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2021
Oral hypomethylating agents: beyond convenience in MDSElizabeth A Griffiths
Current Opinion in Hematology|November 20, 2023
Transfusion avoidance in myelodysplastic neoplasmsElizabeth A Griffiths
Clinical Advances in Hematology & Oncology : H&O|December 30, 2025
Ravulizumab-danicopan combination therapy in PNH managementElizabeth A Griffiths
Leukemia & Lymphoma|April 10, 2008
DNA methyltransferase inhibitors: class effect or unique agents?Elizabeth A Griffiths, Steven D Gore
Blood Reviews|April 1, 2018
To chelate or not to chelate in MDS: That is the question!Amer M Zeidan, Elizabeth A Griffiths
Blood|June 23, 2009
MicroRNA: mIR-ly regulators of DNMT?Elizabeth A Griffiths, Steven D Gore
Lancet (London, England)|April 28, 2023
FLT3-mutated acute myeloid leukaemia: a new opportunityAmanda C Przespolewski, Elizabeth A Griffiths
Cancer Cell|July 9, 2021
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of cautionElizabeth A Griffiths, Brahm H Segal
Advances in Experimental Medicine and Biology|September 8, 2012
Epigenetic therapies in MDS and AMLElizabeth A Griffiths, Steven D Gore
Blood Reviews|February 8, 2020
BITES and CARS and checkpoints, oh my! Updates regarding immunotherapy for myeloid malignancies from the 2018 annual ASH meetingAmanda C Przespolewski, Elizabeth A Griffiths
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Hematology. American Society of Hematology. Education Program|December 10, 2021
Oral hypomethylating agents: beyond convenience in MDSElizabeth A Griffiths
Current Opinion in Hematology|November 20, 2023
Transfusion avoidance in myelodysplastic neoplasmsElizabeth A Griffiths
Clinical Advances in Hematology & Oncology : H&O|December 30, 2025
Ravulizumab-danicopan combination therapy in PNH managementElizabeth A Griffiths
Leukemia & Lymphoma|April 10, 2008
DNA methyltransferase inhibitors: class effect or unique agents?Elizabeth A Griffiths, Steven D Gore
Blood Reviews|April 1, 2018
To chelate or not to chelate in MDS: That is the question!Amer M Zeidan, Elizabeth A Griffiths
Blood|June 23, 2009
MicroRNA: mIR-ly regulators of DNMT?Elizabeth A Griffiths, Steven D Gore
Lancet (London, England)|April 28, 2023
FLT3-mutated acute myeloid leukaemia: a new opportunityAmanda C Przespolewski, Elizabeth A Griffiths
Cancer Cell|July 9, 2021
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of cautionElizabeth A Griffiths, Brahm H Segal
Advances in Experimental Medicine and Biology|September 8, 2012
Epigenetic therapies in MDS and AMLElizabeth A Griffiths, Steven D Gore
Blood Reviews|February 8, 2020
BITES and CARS and checkpoints, oh my! Updates regarding immunotherapy for myeloid malignancies from the 2018 annual ASH meetingAmanda C Przespolewski, Elizabeth A Griffiths
Pageof 13